Two New FDA Rulings Expand Integra’s Product Offerings

Two New FDA Rulings Expand Integra’s Product Offerings (Orthopedics This Week)
Earlier this month, the Food and Drug Administration approved an expanded use for Integra LifeSciences Holdings Corporation’s Vu aPOD, an intervertebral body fusion device (IBD) for use in anterior lumbar fusion (ALIF) procedures. The new indication includes four points of fixation composed of two screws and a SpinPlate.
"Earlier this year the Vu aPOD™ Prime IBD entered its full market release with stand-alone indications," said Kirt Stephenson, president, U.S. Spine. "We're pleased that with this additional indicat...